Clinical Trials Directory

Trials / Completed

CompletedNCT04662814

Extracorporeal Shock Wave Therapy for Dysmenorrhea

the Efficacy of Extracorporeal Shock Wave Therapy for Primary Dysmenorrhea

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
MTI University · Academic / Other
Sex
Female
Age
18 Years – 25 Years
Healthy volunteers
Accepted

Summary

purpose of this study to investigate the effect of Extracorporeal shock wave therapy on pain and prostaglandin level in patient with primary dysmenorrhea

Detailed description

This randomized controlled trial is to determine the effect of shock wave therapy in the treatment of primary dysmenorrhea. females are randomly assigned into 2 groups: group A SWT treatment plus dietary modification during PD (n=25) GROUP B:dietary modification only (n=25); Participants in group B will receive dietary modification for three successive months The numerical rating scale (NRS) and prostaglandin blood level will be recorded and evaluated before and after treatment.

Conditions

Interventions

TypeNameDescription
OTHERshock wave therapyIntervention group is by shock wave therapy. A radial shock wave device (EME, ITALY) was used. for 4 sessions (one session before the expected day of period and session per day for day1 , day 2 and day 3 of each menstrual cycle) for three successive periods.
OTHERdietary modificationParticipants will receive dietary modification for three consecutive months dietary modification will be low caffeine and high water and liquids intake and reduce the uptake of fast food, should be followed for 3 months

Timeline

Start date
2020-09-12
Primary completion
2020-12-24
Completion
2021-01-27
First posted
2020-12-10
Last updated
2021-03-24

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04662814. Inclusion in this directory is not an endorsement.